First Affiliated Hospital of Guiyang College of Traditional Chinese Medicine (TCM), Guiyang, Guizhou, China.
School of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, China.
J Cell Physiol. 2019 Nov;234(11):20816-20828. doi: 10.1002/jcp.28687. Epub 2019 Apr 22.
Cancer stem cells (CSCs) are crucial components of the tumor microenvironment that take part in tumor initiation, progression, recurrence, metastasis, and resistance to chemotherapy. This study explores the mechanisms through which CSCs maintain their stemness, especially in tumors of colorectal cancer (CRC), which thus far remain uncertain. Our findings indicated that the expression of miR-20b-5p is negatively correlated with that of metastasis-associated lung adenocarcinoma transcript-1 (MALAT1, r = -0.928, p = 0.023) and Oct4 (r = -0.894, p = 0.041) in CRC cells. We hypothesized that there may be some targeted regulatory relationships among MALAT1, miR-20b-5p, and Oct4. We proceeded to show that both si-MALAT1 and miR-20b-5p-mimic attenuated microsphere formation and self-renewal capacity, decreased the proportion of CSCs, and downregulated the expression of proteins associated with tumor cell stemness maintenance (Oct4, Nanog, sex-determining region Y-box 2, and Notch1) and cellular metabolism (glucose transporter 1, lactate dehydrogenase B, hexokinase 2, and pyruvate kinase isozyme M2) in HCT-116 cells in vitro. In addition, a xenograft model based on Balb/c mice demonstrated that the administration of either si-MALAT1 or miR-20b-5p-mimic suppressed the tumorigenicity of HCT-116 cells in vivo. The underlying mechanisms may involve the targeting of the tumor cell stemness maintenance-related factor Oct4 by miR-20b-5p. For the first time, we present the possible underlying effects of MALAT1 in influencing the stem cell-like properties of CRC cells. We propose that microRNAs and long noncoding RNAs have vital functions in mediating tumor stemness, which remain to be fully elucidated.
癌症干细胞(CSC)是肿瘤微环境的重要组成部分,参与肿瘤的起始、进展、复发、转移和化疗耐药。本研究探讨了 CSC 维持其干性的机制,特别是在结直肠癌(CRC)肿瘤中,目前仍不确定。我们的研究结果表明,miR-20b-5p 的表达与 CRC 细胞中转移相关的肺腺癌转录物-1(MALAT1,r=-0.928,p=0.023)和 Oct4(r=-0.894,p=0.041)呈负相关。我们假设 MALAT1、miR-20b-5p 和 Oct4 之间可能存在一些靶向调控关系。我们进一步表明,si-MALAT1 和 miR-20b-5p 模拟物均可减弱微球体形成和自我更新能力,降低 CSC 比例,并下调与肿瘤细胞干性维持(Oct4、Nanog、性别决定区 Y 框 2 和 Notch1)和细胞代谢(葡萄糖转运蛋白 1、乳酸脱氢酶 B、己糖激酶 2 和丙酮酸激酶同工酶 M2)相关的蛋白表达。此外,基于 Balb/c 小鼠的异种移植模型表明,si-MALAT1 或 miR-20b-5p 模拟物的给药均可抑制 HCT-116 细胞在体内的致瘤性。潜在机制可能涉及 miR-20b-5p 靶向肿瘤细胞干性维持相关因子 Oct4。我们首次提出 MALAT1 可能通过影响 CRC 细胞的干细胞样特性发挥作用。我们提出,miRNAs 和长链非编码 RNA 在介导肿瘤干细胞特性方面具有重要作用,但其作用机制仍有待进一步阐明。